Evidence map›Paper›PMID 26690656›Full record

ArticleEndocrine2016

Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients.

Francesca Bedussi, Francesca Valcamonico, Alessandra Mosca, Sandra Sigala, Laura Ferrari, Carlo Terrone, Alberto Dalla Volta, Giansilvio Marchioro, Vittorio Ferrari, Oscar Alabiso and 2 more

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in Endocrine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Francesca BedussiOncology Unit, Department of Surgery, Radiology, and Public Health, University of Brescia, Spedali Civili of Brescia, Brescia, Italy.
Francesca ValcamonicoOncology Unit, Department of Surgery, Radiology, and Public Health, University of Brescia, Spedali Civili of Brescia, Brescia, Italy. franzval@yahoo.it.
Alessandra MoscaMedical Oncology, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy.
Sandra SigalaSection of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Laura FerrariOncology Unit, Department of Surgery, Radiology, and Public Health, University of Brescia, Spedali Civili of Brescia, Brescia, Italy.
Carlo TerroneUrology, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy.
Alberto Dalla VoltaOncology Unit, Department of Surgery, Radiology, and Public Health, University of Brescia, Spedali Civili of Brescia, Brescia, Italy.
Giansilvio MarchioroUrology, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy.
Vittorio FerrariOncology Unit, Department of Surgery, Radiology, and Public Health, University of Brescia, Spedali Civili of Brescia, Brescia, Italy.
Oscar AlabisoMedical Oncology, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy.
Maurizio MemoSection of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Alfredo BerrutiOncology Unit, Department of Surgery, Radiology, and Public Health, University of Brescia, Spedali Civili of Brescia, Brescia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAntineoplastic AgentsDocetaxelGonadotropin-Releasing HormoneHumansMaleProstatic NeoplasmsTaxoidsAntineoplastic AgentsDocetaxelGonadotropin-Releasing HormoneTaxoids

Identifiers

PMID26690656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.